For Doctors in a Hurry
- Researchers evaluated the effectiveness of community consultation and public disclosure strategies for emergency research conducted with an exception from informed consent.
- This retrospective review analyzed community engagement plans and summary reports from all twenty clinical sites participating in a pediatric prehospital seizure trial.
- Paid Facebook advertisements achieved a greater median reach of 13992 people compared to 2504 people for free posts to existing institutional followers.
- The authors concluded that paid social media campaigns effectively expand public disclosure reach for emergency trials compared to poorly attended community meetings.
- Future emergency trials should establish standardized social media metrics and develop explicit strategies to engage minoritized populations during community consultation.
Navigating the Ethics of Emergency Pediatric Seizure Research
Severe pediatric epilepsy and convulsive status epilepticus are acute, life-threatening emergencies that demand rapid, evidence-based interventions [1]. While research continues to refine targeted therapies for specific seizure disorders, such as cannabidiol for Dravet syndrome [2], establishing optimal first-line treatments in the prehospital setting remains a persistent clinical challenge. For instance, a network meta-analysis of 1,686 pediatric patients showed that midazolam ranks as the most effective first-line medication for seizure cessation, yet its prehospital implementation is complex [3]. Conducting rigorous trials in these chaotic environments often requires an Exception from Informed Consent (EFIC), a federal provision allowing research when obtaining prior consent is impossible. To maintain ethical integrity, EFIC regulations mandate extensive community consultation and public disclosure before a trial begins. However, investigators frequently struggle to achieve meaningful public engagement, leaving a gap in understanding which outreach strategies are most effective. A new retrospective analysis of a 20-site pediatric trial now offers concrete data on how to best fulfill these critical ethical obligations.
Evaluating Outreach in the PediDOSE Trial
To assess the effectiveness of different public engagement strategies, investigators performed a retrospective review of the Pediatric Dose Optimization for Seizure in Emergency Medical Services (PediDOSE) trial. The analysis examined the community consultation and public disclosure plans from all 20 participating sites. Community consultation refers to the process of gathering feedback from the public about the study, while public disclosure involves informing the community that the research is planned. Using descriptive statistics, the researchers characterized the frequency, reach, and modifications of these outreach plans. The review confirmed that all 20 sites completed their required activities, which commenced in October 2021, providing a comprehensive dataset to evaluate which methods succeeded and which fell short.
The study's findings cast significant doubt on the utility of traditional, in-person community meetings for fulfilling EFIC requirements. Across the 20 trial sites, investigators conducted a total of 52 community consultation meetings. Despite the substantial effort involved, these events were poorly attended. Meetings with community groups had the lowest attendance, with a median of just 9 attendees (interquartile range 2 to 11). Such low turnout raises concerns that the feedback obtained may not be representative of the broader community, potentially undermining a key ethical pillar of the EFIC process. Furthermore, these meetings proved logistically fragile, as they were also the most frequently cancelled community consultation activity. For clinicians and trial coordinators, these data suggest that relying on conventional town hall-style events is an inefficient and unreliable strategy for achieving meaningful public engagement in prehospital emergency research.
In contrast to the challenges of in-person events, digital platforms demonstrated a clear capacity for broad public outreach. The analysis found that a majority of sites (16 of 20) used social media for their community consultation and public disclosure efforts. However, a critical difference emerged based on financial investment: only 4 of the 20 sites allocated funds for paid social media advertisements. This decision had a profound impact on public reach. The data showed that paid advertising on Facebook reached a median of 13,992 people, compared to a median of 2,504 for unpaid posts to existing institutional followers. This nearly six-fold increase in reach was achieved at a reasonable cost, according to the researchers. For physicians designing future EFIC studies, these findings indicate that a dedicated budget for paid digital advertising is a highly efficient and effective method for satisfying federal disclosure requirements and ensuring the community is adequately informed.
Engaging Minoritized Populations and Future Recommendations
The study also examined efforts to ensure outreach was equitable and inclusive. All 20 sites successfully created public disclosure materials and conducted community consultation surveys in Spanish, addressing language barriers for a key demographic. Furthermore, a majority of sites (11 of 20) reported actively recruiting individuals from minoritized populations for their engagement activities, though the success of these efforts varied by location. Based on these collective experiences, the authors offer several data-driven recommendations for future EFIC trials. They strongly advise that investigators utilize paid social media for public disclosure and consider using it to augment community consultation activities. To ensure accountability, they recommend that studies establish standardized metrics for social media success before beginning outreach.
To improve the quality of direct feedback, the authors suggest that any community meetings should include all relevant stakeholder groups, such as patient advocates, community leaders, and first responders. Finally, acknowledging the specific vulnerabilities of the study population, they stress that investigators conducting EFIC trials involving children should develop explicit plans to engage both children and minoritized populations. For practicing physicians involved in clinical research, these recommendations provide a practical framework for designing ethically robust emergency trials that genuinely inform and consult the communities they serve.
References
1. Scheffer IE, Berkovic SF, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017. doi:10.1111/epi.13709
2. Aderinto N, Olatunji G, Kokori E, et al. The efficacy and safety of cannabidiol (CBD) in pediatric patients with Dravet Syndrome: a narrative review of clinical trials.. European journal of medical research. 2024. doi:10.1186/s40001-024-01788-6
3. Zhang Y, Liu Y, Liao Q, Liu Z. Preferential Antiseizure Medications in Pediatric Patients with Convulsive Status Epilepticus: A Systematic Review and Network Meta-Analysis.. Clinical drug investigation. 2021. doi:10.1007/s40261-020-00975-7
